New hope for melasma: common diabetes drug may lighten dark patches
NCT ID NCT07495748
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a metformin cream or a tranexamic acid cream works better for treating melasma, a skin condition causing dark patches on the face. Seventy adults with melasma will apply one of the creams daily for 12 weeks, along with sunscreen. The main goal is to see which cream reduces the size and darkness of the patches more effectively.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MELASMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Fauji Foundation Hospital, Rawalpindi
Rawalpindi, Punjab Province, 44000, Pakistan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple pill make melasma creams work better?
- Can a two-acid cream fade stubborn melasma?
- Can sunscreen do more than protect? study tests if it fades dark spots
- New cream trio aims to outshine standard melasma treatment
- Can sound waves clear up skin? new trial tests ultrasound for pigment and rosacea
- New serums take on hydroquinone in skin brightening showdown